Cargando…
PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
BACKGROUND: Recombinant adeno-associated viruses (rAAV) are commonly used vectors for gene delivery in both basic neuroscience and clinical applications due to their nonpathogenic, minimally immunogenic, and sustained expression properties. However, several challenges remain for the wide-scale rAAV...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716683/ https://www.ncbi.nlm.nih.gov/pubmed/36461117 http://dx.doi.org/10.1186/s40824-022-00322-1 |
_version_ | 1784842745178750976 |
---|---|
author | Zou, Liang Wang, Jinfen Fang, Ying Tian, Huihui |
author_facet | Zou, Liang Wang, Jinfen Fang, Ying Tian, Huihui |
author_sort | Zou, Liang |
collection | PubMed |
description | BACKGROUND: Recombinant adeno-associated viruses (rAAV) are commonly used vectors for gene delivery in both basic neuroscience and clinical applications due to their nonpathogenic, minimally immunogenic, and sustained expression properties. However, several challenges remain for the wide-scale rAAV applications, including poor infection of many clinically important cell lines, insufficient expression at low titers, and diffusive transduction in vivo. METHODS: In this work, PEG, which is a safe and non-toxic polymer of ethylene oxide monomer, was applied as an auxiliary transduction agent to improve the expression of rAAV. In detail, a small dose of PEG was added into the rAAV solution for the transgene expression in cell lines in vitro, and in the central nervous system (CNS) in vivo. The biocompatibility of PEG enhancer was assessed by characterizing the immune responses, cell morphology, cell tropism of rAAV, neuronal apoptosis, as well as motor function of animals. RESULTS: The results show that small dose of PEG additive can effectively improve the gene expression characteristics of rAAV both in vitro and in vivo. Specifically, the PEG additive allows efficient transgene expression in cell lines that are difficult to be transfected with rAAV alone. In vivo studies show that the PEG additive can promote a spatially confined and efficient transgene expression of low-titer rAAV in the brain over long terms. In addition, no obvious side effects of PEG were observed on CNS in the biocompatibility studies. CONCLUSIONS: This spatially confined and efficient transduction method can facilitate the applications of rAAV in fundamental research, especially in the precise dissection of neural circuits, and also improve the capabilities of rAAV in the treatment of neurological diseases which originate from the disorders of small nuclei in the brain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-022-00322-1. |
format | Online Article Text |
id | pubmed-9716683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97166832022-12-03 PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery Zou, Liang Wang, Jinfen Fang, Ying Tian, Huihui Biomater Res Research Article BACKGROUND: Recombinant adeno-associated viruses (rAAV) are commonly used vectors for gene delivery in both basic neuroscience and clinical applications due to their nonpathogenic, minimally immunogenic, and sustained expression properties. However, several challenges remain for the wide-scale rAAV applications, including poor infection of many clinically important cell lines, insufficient expression at low titers, and diffusive transduction in vivo. METHODS: In this work, PEG, which is a safe and non-toxic polymer of ethylene oxide monomer, was applied as an auxiliary transduction agent to improve the expression of rAAV. In detail, a small dose of PEG was added into the rAAV solution for the transgene expression in cell lines in vitro, and in the central nervous system (CNS) in vivo. The biocompatibility of PEG enhancer was assessed by characterizing the immune responses, cell morphology, cell tropism of rAAV, neuronal apoptosis, as well as motor function of animals. RESULTS: The results show that small dose of PEG additive can effectively improve the gene expression characteristics of rAAV both in vitro and in vivo. Specifically, the PEG additive allows efficient transgene expression in cell lines that are difficult to be transfected with rAAV alone. In vivo studies show that the PEG additive can promote a spatially confined and efficient transgene expression of low-titer rAAV in the brain over long terms. In addition, no obvious side effects of PEG were observed on CNS in the biocompatibility studies. CONCLUSIONS: This spatially confined and efficient transduction method can facilitate the applications of rAAV in fundamental research, especially in the precise dissection of neural circuits, and also improve the capabilities of rAAV in the treatment of neurological diseases which originate from the disorders of small nuclei in the brain. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-022-00322-1. BioMed Central 2022-12-02 /pmc/articles/PMC9716683/ /pubmed/36461117 http://dx.doi.org/10.1186/s40824-022-00322-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zou, Liang Wang, Jinfen Fang, Ying Tian, Huihui PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title | PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title_full | PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title_fullStr | PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title_full_unstemmed | PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title_short | PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery |
title_sort | peg-mediated transduction of raav as a platform for spatially confined and efficient gene delivery |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716683/ https://www.ncbi.nlm.nih.gov/pubmed/36461117 http://dx.doi.org/10.1186/s40824-022-00322-1 |
work_keys_str_mv | AT zouliang pegmediatedtransductionofraavasaplatformforspatiallyconfinedandefficientgenedelivery AT wangjinfen pegmediatedtransductionofraavasaplatformforspatiallyconfinedandefficientgenedelivery AT fangying pegmediatedtransductionofraavasaplatformforspatiallyconfinedandefficientgenedelivery AT tianhuihui pegmediatedtransductionofraavasaplatformforspatiallyconfinedandefficientgenedelivery |